Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Thoracic Cancer|February 12, 2020
Clinical diagnosis and treatment of immune checkpoint inhibitors-related endocrine dysfunctionLian Duan, Linjie Wang, Hanping Wang, et al.
Thoracic Cancer|April 21, 2020
Opportunistic infections complicating immunotherapy for non-small cell lung cancerZiwei Liu, Tao Liu, Xiaotong Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 26, 2019
[Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors]Lian Duan, Linjie Wang, Xiaoyan Si, et al.
Thoracic Cancer|December 10, 2019
Management of immune checkpoint inhibitor-related dermatologic adverse eventsXiaoyan Si, Chunxia He, Li Zhang, et al.
Frontiers in Immunology|July 18, 2022
Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Asian Journal of Pharmaceutical Sciences|April 20, 2026
An exosome-inspired docetaxel prodrug nanoplatform for potent STING activation and synergistic chemoimmunotherapyXinying Wang, Xianlu Zhang, Zixuan Jiao, et al.
Frontiers in Oncology|April 8, 2022
Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in ChinaKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Frontiers in Immunology|December 26, 2022
Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non- small cell lung cancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Pageof 12